Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study
Sculpher, Mark J., Poole, Lynne, Cleland, John, Drummond, Michael, Armstrong, Paul W., Horowitz, John D., Massie, Barry M., Poole-Wilson, Philip A., Ryden, LarsVolume:
2
Language:
english
Journal:
European Journal of Heart Failure
DOI:
10.1016/S1388-9842(00)00122-7
Date:
December, 2000
File:
PDF, 161 KB
english, 2000